Waters WAT · NYSE
$443.96 +2.23% (+$9.69)
Summary
37 / 100 · Bulios Score
What speaks for it
- Analysts expect revenue to grow by 104% this fiscal year.
- It beat profit estimates 8 times in the last 8 quarters.
What to watch
- Repaying its net debt would take 5.3 years of operating profit.
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 2.8% a year over the last 3 years.
- It earns only 1.3 USD a year on every 100 USD of invested capital.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 256.7 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 6.0% a year over 5 years. Over the last 3 years it grew by 2.1% a year. For the next fiscal year analysts expect revenue to grow by 104%. Earnings per share fell by 2.8% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 49 USD
- Research and development 6.9 USD
- Sales and administration 36 USD
- Taxes and other 4.4 USD
- Net profit 3.6 USD
Net profit, industry median (Medical - Diagnostics & Research) 8.8 USD
Out of every 100 USD of revenue, 3.6 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 13.3 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 19
- Hold 16
- Sell 2
Today's price within the analysts' price targets
The average target of $450.17 is 1.3% above today's price. 51% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Waters Instrument Systems 35%
- Waters Service 34%
- Chemistry Consumables 20%
- Ta Instrument Systems 7.7%
- Ta Service 3.4%
By region
- Americas 37%
- Asia Pacific 33%
- Europe 30%
Waters Instrument Systems brings in 35% of revenue. Chemistry Consumables grew fastest, by 5.6% a year.
Segments in detail